Valuation: Alembic Pharmaceuticals Limited

Market Cap 162B 1.68B 1.47B 1.36B 1.25B 2.36B 2.41B 16.23B 6.38B 79.43B 6.32B 6.19B 273B P/E 2027 *
21.8x
P/E 2028 * 17.1x
Enterprise Value 172B 1.78B 1.56B 1.44B 1.32B 2.5B 2.55B 17.18B 6.76B 84.05B 6.69B 6.55B 289B EV / Sales 2027 *
2.09x
EV / Sales 2028 * 1.81x
Free-Float
29.3%
Yield 2027 *
1.56%
Yield 2028 * 1.85%
1 day-1.74%
1 week-1.47%
Current month+0.29%
1 month+10.58%
3 months+5.14%
6 months+6.48%
Current year-2.49%
1 week 811.05
Extreme 811.05
855.4
1 month 744.35
Extreme 744.35
855.4
Current year 635.8
Extreme 635.8
855.4
1 year 635.8
Extreme 635.8
1,038
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 2025-07-06
Chief Tech/Sci/R&D Officer - 2023-06-30
Chief Operating Officer - 2025-07-20
Director TitleAgeSince
Chairman 78 2012-06-07
Director/Board Member 50 2006-12-31
Director/Board Member 66 2003-01-17
Date Insider Type Main position Quantity % Market Cap.
3/28/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
3/24/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
3/21/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.74%-1.47%-20.36%+24.62% 1.68B
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -0.28%+0.34%+23.28%+52.70% 357.67B
Weighted average by Cap. +0.21%+0.02%+37.72%+81.47%

Financials

2027 *2028 *
Net sales 82.16B 853M 746M 688M 634M 1.2B 1.22B 8.22B 3.23B 40.24B 3.2B 3.13B 139B 90.29B 938M 819M 756M 697M 1.31B 1.34B 9.04B 3.55B 44.22B 3.52B 3.44B 152B
Net income 7.51B 78.01M 68.18M 62.91M 57.99M 109M 112M 752M 296M 3.68B 293M 287M 12.67B 9.52B 98.83M 86.37M 79.7M 73.46M 138M 142M 953M 375M 4.66B 371M 363M 16.05B
Net Debt 9.43B 97.93M 85.58M 78.97M 72.79M 137M 140M 944M 371M 4.62B 368M 360M 15.9B 1.32B 13.66M 11.94M 11.02M 10.16M 19.14M 19.57M 132M 51.8M 644M 51.32M 50.19M 2.22B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
26-07-17 ₹825.10 -1.74% 70,744
26-07-16 ₹839.75 -1.21% 92,763
26-07-15 ₹850.05 +3.52% 207,604
26-07-14 ₹821.15 -1.19% 122,575
26-07-13 ₹831.05 -0.76% 101,420
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
825.10INR
Average target price
918.20INR
Spread / Average Target
+11.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock